ENT Devices Market

Global ENT Devices Market Size (2024 to 2029)

The global ENT devices market is forecasted to be growing at a CAGR of 7.4% from 2024 to 2029 and will be worth USD 24.91 billion by 2029 from USD 17.43 billion in 2024.

ENT devices are designed to aid in the treatment and diagnostic procedures for the ears, nose and throat. An ENT specialist uses these devices to help the patient with different problems in these parts of the body. These instruments are regularly used in surgeries and treatment procedures such as aural forceps and nasal forceps. An otolaryngologist is a trained professional who is educated in the use of these devices and assists in the application. Some of the most common instruments in the ENT industry are Nasal Speculum, Tongue depressor, Laryngeal mirrors and others.

MARKET DRIVERS

The growing patient population of ENT problems worldwide majorly drives the global ENT devices market.

According to WHO 1 in 4 people (2.5 billion) are expected to suffer from hearing problems by 2050 and oral diseases affect around 3.5 billion people. The growing incidence of sinusitis, rhinitis and allergies further contributes to the market’s growth rate as these problems need an instrumental examination for diagnosis and treatment purposes. Furthermore, the rising advancements in ENT devices with research and an increasing number of innovations support the ENT devices market growth. The growing adoption of technological advancements to develop new and improved ENT devices promote market growth.

The rising prevalence of several ENT problems such as vertigo, lumps in the throat, chronic stuffy nose, sleep apnea, hearing loss and chronic ear infections fuels the growth rate of the ENT devices market. These diseases require the immediate assistance of an ENT specialist and an increasing number of patients suffering from these diseases is boosting the demand for ENT devices. The growing number of undiagnosed cases of ENT problems resulting in emergency situations adds to the rising demand for ENT devices and contributes to market growth. For instance, an estimated 18 million cases of sleep apnea go undiagnosed in the U.S. The growing shortage of ENT specialists in low-income countries, the rising prevalence of ENT surgeries and the instruments required for performing these complex procedures support the market growth. As per a report published by World Health Organization (WHO), an estimated 78% of the population has less than one ENT specialist per million population in low-income countries. Such factors are anticipated to result in an increased demand for ENT devices in low-income countries to meet treatment needs.

The growing awareness among the healthcare professionals and patient population regarding the benefits of ENT devices and increasing healthcare expenditure in several countries further boost the growth rate of the market. The growing awareness of ENT disorders among people has resulted in a rise in the number of individuals seeking medical assistance for their symptoms. Governments and private organizations have been investing considerable amounts in improving patient access to ENT devices and treatments in developing and underdeveloped countries.

MARKET RESTRAINTS

High costs associated with ENT devices are one of the major factors hampering the market growth. Due to these high costs, consumers do not prefer to pay frequently for ENT as many people still consider it non-essential. Poor awareness among healthcare professionals and patients regarding the various ENT devices available and their potential benefits is another significant roadblock to market growth. Limited reimbursement policies for ENT devices, stringent regulatory requirements and technological limitations of ENT devices further inhibit the market growth.

Impact of COVID-19 on the global ENT devices market

The lockdowns caused by the COVID-19 pandemic have given a huge blow to the ENT devices market as the ENT clinics were all shut down and the operations were shut down as it did not fall under emergency criteria, hence operations were only performed as and when required as the last option. This led to a reduction in the sales of the ENT devices. The market suffered due to the restrictions imposed in most of the markets across the globe. However, increased demand for certain ENT devices was seen since the middle of the COVID-19 pandemic and the acceleration in the demand levels for these devices has started from there and continued. It is because of the growing use of telemedicine tools such as video otoscopes by healthcare providers to minimize face-to-face interactions with patients. The demand for disposable otoscopes and other single-use devices has also increased owing to the growing importance of personal protective equipment (PPE). Likewise, the COVID-19 pandemic had a mixed impact on the global ENT devices market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global ENT Devices Market Analysis By Product

Based on product, the hearing aids segment had the largest share of the global market in 2023 and is also expected to register the fastest CAGR during the forecast period. The growing patient population suffering from hearing loss, growing awareness about the benefits of hearing aids and technological advancements such as Bluetooth-enabled devices and rechargeable batteries majorly drive the segmental growth. As per the statistics published by World Health Organization (WHO), an estimated 1.5 billion people worldwide currently live with hearing loss and this number is predicted to rise 2.5 billion by the end of 2050.

On the other hand, the surgical devices segment is also estimated to witness a notable CAGR during the forecast period. Factors such as technological advancements, the rising prevalence of ENT disorders, growing demand for minimally invasive surgeries and the development of new surgical devices, such as robotic surgical systems and 3D-printed implants propel the segmental growth.

Global ENT Devices Market Analysis By Device Type

Based on the device type, the endoscopes segment occupied the largest share of the global ENT Devices market in 2023 and the domination of the segment is likely to continue during the forecast period. The growing prevalence of ENT disorders such as sinusitis, otitis media and laryngeal cancer, the development of technologically well-advanced endoscopes with features such as high-definition imaging, improved ergonomics, and better visualization and rising demand for minimally invasive surgeries primarily boost the segmental growth. Factors such as the growing aging population, rising patient awareness about the benefits of endoscopic procedures for ENT disorders and favorable reimbursement policies for endoscopic procedures by insurance providers and governments further promote the segmental growth.

The hearing screening devices segment is also expected to have considerable growth during the forecast period owing to the rising prevalence of hearing loss, particularly among aging populations, the development of technologically advanced hearing screening devices with features such as digital sound processing, wireless connectivity and improved accuracy and the growing patient awareness about the importance of early detection and treatment of hearing loss. The rising popularity of at-home medical devices, the increasing number of initiatives to improve hearing health, such as free hearing screenings and educational programs and the increasing adoption of new-born hearing screening programs in hospitals and clinics further contribute to the segmental growth.

Global ENT Devices Market Analysis By End-User

Based on end-user, the hospitals and ambulatory settings segment held the major share of the worldwide market in 2023 and the same trend is estimated to continue during the forecast period owing to factors such as growing disposable income, increasing affordability for ENT treatment, rising number of improvements in the healthcare infrastructure and expenditure among the developing countries and growing awareness of the success or failure rates of procedures.

On the other hand, the ENT clinics segment is anticipated to hold a promising share of the worldwide market during the forecast period. The growing number of ENT clinics worldwide is one of the key factors propelling segmental growth. In addition, the unavailability of appointments for ENT doctors in hospitals and more professionals setting up individual clinics support the segmental growth. The growing proximity of ENT clinics and negotiable treatment costs favors segmental growth.

REGIONAL ANALYSIS

North America dominated the ENT devices market in 2023 and the regional domination is anticipated to continue during the forecast period. The growing patient population of ENT diseases, such as chronic sinusitis and sleep apnea, rising awareness about advanced treatment options, the presence of key market players, favorable reimbursement policies and advanced healthcare infrastructure majorly drive the North American ENT devices market. The rising demand for minimally invasive ENT procedures, technological advancements in ENT devices, increasing geriatric population and growing healthcare expenditure further boost the growth rate of the North American market. The U.S. held the largest share of the North American market in 2023 and the domination of the U.S. market is predicted to continue during the forecast period owing to the growing number of people suffering from chronic sinusitis and increasing aging population. An estimated 30 million in the U.S. suffer from chronic sinusitis in the U.S. every year. As per the data published by the Urban Institute, the number of Americans ages 65 and older is expected to reach 80 million by 2040.

APAC is predicted to register the fastest CAGR in the worldwide market during the forecast period. Factors such as the large patient pool with ENT disorders, increasing number of improvements in the healthcare infrastructure, rising medical tourism industry in APAC and growing awareness about ENT disorders among the population of APAC countries support the regional market growth. The growing disposable income and rising prevalence of noise-induced hearing loss further propel the ENT devices market in the Asia-Pacific region. China and Japan accounted for the major share of the APAC market in 2023 and these countries are also estimated to control a substantial share of the APAC market during the forecast period. India is predicted to witness the fastest CAGR during the forecast period owing to the growing patient population of hearing loss. As per the WHO data, an estimated 63 million people in India have hearing issues.

Europe is another prominent regional market for ENT devices and is expected to hold a substantial share of the global market during the forecast period owing to factors such as the increasing geriatric population, rising prevalence of chronic obstructive pulmonary disease (COPD) leading to ENT disorders and the presence of favorable government initiatives and funding for ENT devices. The growing adoption of advanced technologies, growing healthcare expenditure and rising prevalence of sleep apnea among the European population further accelerate the growth rate of the European market. Germany and UK captured the largest share of the European market in 2023.

Latin America is another noteworthy regional market for ENT devices worldwide and is expected to register a healthy CAGR during the forecast period owing to the rapid adoption of ENT devices, the growing medical tourism industry and growing healthcare expenditure. Brazil had the major share of the Latin American market in 2023 and is expected to continue playing the leading role in the Latin American market during the forecast period owing to the rising prevalence of hearing loss.

MEA occupied a moderate share of the global market in 2023 and is projected to register a steady CAGR during the forecast period.

KEY MARKET PARTICIPANTS

Companies currently dominating the global ENT devices market and profiled in this report are Johnson & Johnson Services, Inc. (DePuy Synthes), Stryker, Zimmer Biomet, Orthofix Medical, Inc., B. Braun Melsungen AG, Medtronic, NuVasive, Inc., Globus Medical, ATEC Spine, Inc., Captiva Spine, Inc., SeaSpine, Spinal Elements, Inc., Spine Wave, Inc., Spineology, Inc., and Xtant Medical Holdings, Inc.

RECENT HAPPENINGS IN THE MARKET

• In February 2022, Baylis Medical Company Inc. was acquired by Boston Scientific Corporation. Baylis Medical Company Inc. provides trans septal access solutions, guidewires, sheaths and dilators for catheter-based left-heart procedures are now under Boston Scientific Corporation and the company aims to bring forth advanced research and development with this acquisition.
• In June 2022, ShengWang was acquired by Demant. Demant achieved full ownership of ShengWang, the top network of hearing aid clinics in China, by acquiring the remaining 80% of its shares.
• In January 2022, the Livio AI Edge, a new hearing aid from Starkey Hearing Technologies utilizes artificial intelligence to enhance hearing capabilities and can keep track of an individual's physical and cognitive well-being.
• In February 2021, the LATERA nasal implant was granted clearance by the FDA. This implant is designed to provide support to the lateral nasal wall and alleviate nasal airway obstruction.

This research report on the global ENT devices market has been segmented and sub-segmented based on product, devices, end-user & region.

By Product

• Diagnostic Devices
• Surgical Devices
• Hearing Aids
• Hearing Implants
• Co2 Lasers
• Image-Guided Surgery Systems

By Device Type

• Endoscopes
• Hearing Screening Devices

By End-User

• Home Use
• Hospitals and Ambulatory Settings
• ENT Clinics

By Region

• North America
• Asia Pacific
• Europe
• Latin America
• The Middle East and Africa